Wider Debate Swirls Over Ruling That Curtailed Berkeley's DNA Program
By Josh Keller,
The Chronicle of Higher Education
| 08. 19. 2010
After months of debate, a ruling by the California Department of Public Health last week put an end to the most controversial part of a student DNA-testing project at the University of California at Berkeley, but now another debate has opened over how academic research will be affected.
Some researchers fear that the health department's position on the Berkeley project could have broader implications for academic research in California, limiting the conditions under which subjects of research studies could learn about potential health issues. Others say those concerns are unfounded.
Berkeley's plan to teach incoming freshmen about personal genetics by allowing them to obtain personal results for three genetic markers sparked a political firestorm. The program put Berkeley in the middle of a heated national debate over the ethics of personal DNA testing, driven by rapid scientific advances and the explosive growth of the personal-testing industry.
State lawmakers unsuccessfully tried to pass a bill to discourage the project, and advocacy groups and some researchers called the program unwise and potentially unethical. Last week, state health regulators said that as long...
Related Articles
By Staff, GMWatch | 03.28.2026
Following a recent podcast interview we were asked whether there is any solid scientific research looking at how gene expression or molecular composition in genetically modified (GM) plants differs from conventionally bred plants. As this is an interesting and important...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
By Ryan Cross, Endpoints News | 03.24.2026
Cathy Tie has an audacity more typical of a tech startup founder than a biotech executive. She dropped out of college to start a genetic screening company and later founded a telemedicine startup. The 29-year-old has been on two Forbes...
By Rowan Walrath and Laurel Oldach, Chemical & Engineering News | 03.04.2026
Washington, DC—At a press conference held at the US Department of Health and Human Services headquarters on Feb. 23, two doctors from the University of Pennsylvania and Children’s Hospital of Philadelphia spoke about their hope for the future of...